Form D · Private Equity Fund
Arrivo BioVentures, LLC
Morrisville, NC · CIK 0001674649
Offering snapshot reported Nov 29, 2023 · SEC filing
- Reported sold
- $43.2M Offering amount: $45.3M
- Investors reported
- 58 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 17, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 29, 2023 | Initial | $43,194,016 | No comparison | 58 | SEC filing |
| May 25, 2016 | Initial | $49,000,000 | No comparison | 34 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-498306
Source: Form D, filed Nov 29, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Karen Adams | Executive |
| Stephen E. Butts | Executive |
| William N. Wofford | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3000 Rdu Center Drive Suite 130
Morrisville, NC, 27560
Morrisville, NC, 27560